Literature DB >> 18492688

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.

Pier Paolo Piccaluga1, Andrea Califano, Ulf Klein, Claudio Agostinelli, Beatriz Bellosillo, Eva Gimeno, Sergi Serrano, Francisco Solè, Yonghui Zang, Brunangelo Falini, Pier Luigi Zinzani, Stefano A Pileri.   

Abstract

BACKGROUND: Follicular lymphomas are currently subdivided into grades I, II, IIIa and IIIb. This distinction is, however, questioned. DESIGN AND METHODS: We studied the gene expression profile of 43 follicular lymphomas, 50 B-cell non-Hodgkin's lymphomas of different histotype, and 20 samples of normal B-lymphocytes in order to assess: (i) the relationship of follicular lymphoma with normal B cells and other B-cell non-Hodgkin's lymphomas; (ii) whether follicular lymphoma is a unique disease; and (iii) whether follicular lymphoma grade IIIb is closer to follicular lymphoma or diffuse large B-cell lymphoma of the germinal center B-cell type.
RESULTS: First, we found that the molecular profile of follicular lymphoma is intimately related to that of normal germinal center B cells, irrespectively of the histological grade. Secondly, we observed that follicular lymphoma has a relatively homogeneous gene expression profile that is distinct from that of other B-cell non-Hodgkin's lymphoma and does not include discrete molecular subgroups. However, by further clustering samples according to signatures differentially expressed among follicular lymphomas or in follicular lymphomas versus diffuse large B-cell lymphoma, we showed that grade I-IIIa tumors tend to cluster together, while grade IIIb follicular lymphoma constitutes a distinct subgroup, whose molecular signature is closer to that of the remaining follicular lymphomas than to that of diffuse large B-cell lymphoma of the germinal center B-cell type.
CONCLUSIONS: These data support the hypothesis that grade IIIb follicular lymphoma does indeed belong to the group of follicular lymphomas rather than diffuse large B-cell lymphomas, and also suggests a possible revision of the histological grading of follicular lymphomas, with their simple distinction into follicular lymphoma (grade I-IIIa) and follicular lymphoma/large cell (grade IIIb).

Entities:  

Mesh:

Year:  2008        PMID: 18492688     DOI: 10.3324/haematol.12754

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  19 in total

Review 1.  Recommendations for Clinical Trial Development in Follicular Lymphoma.

Authors:  Kami Maddocks; Paul M Barr; Bruce D Cheson; Richard F Little; Lawrence Baizer; Brad S Kahl; John P Leonard; Nathan Fowler; Leo I Gordon; Brian K Link; Jonathan W Friedberg; Stephen M Ansell
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

Review 2.  The bone marrow stroma in hematological neoplasms--a guilty bystander.

Authors:  Claudio Tripodo; Sabina Sangaletti; Pier P Piccaluga; Sonam Prakash; Giovanni Franco; Ivan Borrello; Attilio Orazi; Mario P Colombo; Stefano A Pileri
Journal:  Nat Rev Clin Oncol       Date:  2011-03-29       Impact factor: 66.675

3.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

Review 4.  Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.

Authors:  Kirsten M Boughan; Paolo F Caimi
Journal:  Curr Oncol Rep       Date:  2019-05-23       Impact factor: 5.075

5.  Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.

Authors:  Heike Horn; Christopher Schmelter; Ellen Leich; Itziar Salaverria; Tiemo Katzenberger; M Michaela Ott; Jörg Kalla; Monica Romero; Reiner Siebert; Andreas Rosenwald; German Ott
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

Review 6.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

7.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

8.  The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Authors:  Mohsen Navari; Maryam Etebari; Giulia De Falco; Maria R Ambrosio; Davide Gibellini; Lorenzo Leoncini; Pier Paolo Piccaluga
Journal:  Front Microbiol       Date:  2015-06-10       Impact factor: 5.640

9.  IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Fabio Fuligni; Simona Righi; Claudio Tripodo; Maria Carla Re; Alberto Clò; Anna Miserocchi; Silvia Morini; Marisa Gariglio; Gian Gaetano Ferri; Alberto Rinaldi-Ceroni; Ottavio Piccin; Marco De Andrea; Stefano A Pileri; Santo Landolfo; Davide Gibellini
Journal:  J Immunol Res       Date:  2015-06-22       Impact factor: 4.818

10.  The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin.

Authors:  Maria R Ambrosio; Pier P Piccaluga; Maurilio Ponzoni; Bruno J Rocca; Valeria Malagnino; Monica Onorati; Giulia De Falco; Valeria Calbi; Martin Ogwang; Kikkeri N Naresh; Stefano A Pileri; Claudio Doglioni; Lorenzo Leoncini; Stefano Lazzi
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.